Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Becton Dickinson and Co (BDX) vs Wix.Com Ltd (WIX) Price & Performance

Becton Dickinson and CoTrade
Wix.Com LtdTrade

Price performance (Past 24H)

Key statistics

Becton Dickinson and Co vs Wix.Com Ltd — how do they compare? Becton Dickinson and Co trades at $181.29 (market cap $48.93B), while Wix.Com Ltd trades at $66.7 (market cap $2.61B). The key difference: Becton Dickinson and Co is far larger — about 18.7× Wix.Com Ltd's market cap, and Becton Dickinson and Co pays a 2.34% dividend while Wix.Com Ltd pays none. Which is the better fit depends on your goals.

BDXWIX
Market Cap
$48.93B$2.61B
Sector
HealthTechnology
52-Week High
$185.39$184.24
52-Week Low
$138.62$40.43
Enterprise Value
$65.03B$3.69B
Dividend Yield
2.34%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Becton Dickinson and Co

BDX (Becton, Dickinson and Company) trades at $176.86, down 0.12% on the day, with a bullish technical outlook supported by moving averages and strong earnings beats in recent quarters. The company reported Q3 2026 revenue of $5.0 billion, up 4.4% FX-neutral, and raised full-year guidance, though margins faced pressure. Analyst sentiment is mixed with a consensus price target of $183.00, while institutional ownership remains stable amid positive news on GLP-1 therapy expansions and dividend declarations.

The stock offers steady growth potential with a 2.7% dividend yield and consistent earnings outperformance, but risks include margin compression, regulatory recalls, and high valuation multiples. Near-term resistance at $180 and support at $173 will test bullish momentum, with the current price near the consensus target suggesting limited upside without further catalysts.

Wix.Com Ltd

Wix trades at $60.20, down 1.12% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $79.75 suggesting significant upside. Revenue grew to $1.99 billion in 2025, though net income margin remains negative at -8.19%. Recent earnings show three beats and one miss in the last four quarters, with a notable 27% price drop following the Q1 2026 miss.

The outlook is mixed: strong revenue growth and analyst optimism contrast with profitability challenges and a securities class action lawsuit alleging misleading statements. The stock offers potential for appreciation if execution improves, but faces near-term legal and operational risks that could pressure the share price.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Becton Dickinson and Co

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

Read more on BDX

About Wix.Com Ltd

Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.

Read more on WIX